Michael Bernd Ranke
#125,941
Most Influential Person Now
Michael Bernd Ranke's AcademicInfluence.com Rankings
Michael Bernd Rankephilosophy Degrees
Philosophy
#5895
World Rank
#8824
Historical Rank
Logic
#3105
World Rank
#4215
Historical Rank
Michael Bernd Rankebiology Degrees
Biology
#7959
World Rank
#10961
Historical Rank
Endocrinology
#83
World Rank
#94
Historical Rank
Genetics
#776
World Rank
#868
Historical Rank
Molecular Biology
#964
World Rank
#987
Historical Rank
Download Badge
Philosophy Biology
Michael Bernd Ranke's Degrees
- Doctorate Medicine Stanford University
Why Is Michael Bernd Ranke Influential?
(Suggest an Edit or Addition)Michael Bernd Ranke's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome (1997) (894)
- A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. (1990) (479)
- Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. (1993) (434)
- Recommendations for the diagnosis and management of Turner syndrome. (2001) (395)
- Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy (1998) (367)
- Serum Insulin-Like Growth Factor I Reference Values for an Automated Chemiluminescence Immunoassay System: Results from a Multicenter Study (2003) (352)
- Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. (1989) (333)
- Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment (2000) (278)
- Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) (2004) (271)
- Towards a consensus on the definition of idiopathic short stature. (1996) (269)
- Derivation and Validation of a Mathematical Model for Predicting the Response to Exogenous Recombinant Human Growth Hormone (GH) in Prepubertal Children with Idiopathic GH Deficiency (1999) (261)
- The ratio between serum levels of insulin‐like growth factor (IGF)‐I and the IGF binding proteins (IGFBP‐1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients (1994) (250)
- Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. (2001) (208)
- Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). (1993) (203)
- Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. (2006) (184)
- Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database). (2003) (183)
- Reference Ranges for Serum Concentrations of Lutropin (LH), Follitropin (FSH), Estradiol (E2), Prolactin, Progesterone, Sex Hormone-Binding Globulin (SHBG), Dehydroepiandrosterone Sulfate (DHEAS), Cortisol and Ferritin in Neonates, Children and Young Adults (2002) (180)
- Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. (1990) (178)
- The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. (2006) (167)
- Reference Intervals from Birth to Adulthood for Serum Thyroxine (T4), Triiodothyronine (T3), free T3, free T4, Thyroxine Binding Globulin (TBG) and Thyrotropin (TSH) (2001) (162)
- Phenotype: genotype relationships in growth hormone insensitivity syndrome. (1997) (160)
- Clinical studies of IGFBP-2 by radioimmunoassay. (1993) (160)
- A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I. (1988) (159)
- Noonan syndrome: growth and clinical manifestations in 144 cases (1988) (158)
- Growth hormone — past, present and future (2018) (155)
- Growth and symptoms in Silver-Russell syndrome: Review on the basis of 386 patients (1995) (153)
- Ketoacidosis at onset of type 1 diabetes mellitus in children – frequency and clinical presentation (2003) (151)
- Turner's syndrome (2001) (150)
- The Use of Bone Age in Clinical Practice – Part 1 (2011) (150)
- Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. (2004) (147)
- PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome. (2005) (144)
- Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables. (2010) (143)
- A role for helix 3 of the TRβ ligand‐binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone (1998) (142)
- Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective (2019) (137)
- Prediction of Long-Term Response to Recombinant Human Growth Hormone in Turner Syndrome: Development and Validation of Mathematical Models (2000) (137)
- Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. (2005) (125)
- Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. (1998) (125)
- Characterization of somatogenic and lactogenic binding sites in isolated rat hepatocytes. (1976) (120)
- Decreased serum levels of insulin‐like growth factors and IGF binding protein 3 in osteoporosis (1993) (118)
- Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. (1999) (114)
- Long-Term Treatment of Growth Hormone Insensitivity Syndrome with IGF-I (1999) (112)
- Energy Expenditure, Energy Intake and Prevalence of Obesity after Therapy for Acute Lymphoblastic Leukemia during Childhood (2000) (110)
- Age at Growth Hormone Therapy Start and First-Year Responsiveness to Growth Hormone Are Major Determinants of Height Outcome in Idiopathic Short Stature (2007) (110)
- Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature. (2003) (108)
- Use of insulin-like growth factor-binding protein 3 for the evaluation of growth disorders. (1990) (107)
- Screening for growth hormone (GH) gene splice-site mutations in sporadic cases with severe isolated GH deficiency using ectopic transcript analysis. (1995) (102)
- Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. (1991) (101)
- A solid-phase radioimmunoassay for detection of IgM antibodies to hepatitis A virus. (1979) (101)
- Diagnostics of endocrine function in children and adolescents (2003) (100)
- Functional role of insulin-like growth factor binding proteins. (1997) (100)
- Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone. (2000) (99)
- Is maternal duplication of 11p15 associated with Silver-Russell syndrome? (2005) (98)
- Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study. (1997) (96)
- Musculoskeletal abnormalities of the forearm in patients with juvenile idiopathic arthritis relate mainly to bone geometry. (2004) (94)
- Insulin-like growth factor I improves height in growth hormone insensitivity: two years' results. (1995) (91)
- Predicting growth in response to growth hormone treatment. (2009) (90)
- Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia (1991) (89)
- The endocrine phenotype in silver-russell syndrome is defined by the underlying epigenetic alteration. (2008) (89)
- Epigenetic mutations in 11p15 in Silver-Russell syndrome are restricted to the telomeric imprinting domain (2005) (88)
- Significance of Basal IGF-I, IGFBP-3 and IGFBP-2 Measurements in the Diagnostics of Short Stature in Children (2001) (88)
- ESPE Classification of Paediatric Endocrine Diagnoses (2007) (88)
- Growth hormone therapy in pediatrics : 20 years of KIGS (2007) (87)
- Reference values for height and weight in Prader-Willi syndrome based on 315 patients (1998) (86)
- Growth hormone treatment and adverse events in Prader–Willi syndrome: data from KIGS (the Pfizer International Growth Database) (2006) (83)
- Magnetic resonance images of 91 children with different causes of short stature: pituitary size reflects growth hormone secretion (1997) (82)
- Pelvic ultrasonography: Early differentiation between isolated premature thelarche and central precocious puberty (1995) (79)
- Insulin-like growth factor I concentrations in infancy predict differential gains in body length and adiposity: the Cambridge Baby Growth Study. (2009) (78)
- Isolated GH deficiency with dominant inheritance: new mutations, new insights. (2001) (77)
- Prediction of adult height based on automated determination of bone age. (2009) (77)
- SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity. (2004) (76)
- Relevance of IGF-I, IGFBP-3, and IGFBP-2 Measurements during GH Treatment of GH-Deficient and Non-GH-Deficient Children and Adolescents (2001) (75)
- Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function (2006) (75)
- Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001. (2002) (75)
- Efficacy and Safety of Growth Hormone Treatment in Children with Prior Craniopharyngioma: An Analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996 (1998) (75)
- Growth hormone, somatomedin levels and growth regulation in Turner's syndrome. (1987) (75)
- Personalized Approach to Growth Hormone Treatment: Clinical Use of Growth Prediction Models (2013) (74)
- Clinical application of automated Greulich-Pyle bone age determination in children with short stature (2009) (73)
- The Use of Bone Age in Clinical Practice – Part 2 (2011) (73)
- Antioxidant deficiency in cystic fibrosis: when is the right time to take action? (2004) (72)
- Diagnosis and Treatment of Growth Hormone Deficiency in Children and Adolescents: Towards a Consensus (1998) (71)
- Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays. (2008) (70)
- Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. (2013) (69)
- Insulin-like growth factor binding-protein-3 (IGFBP-3). (2015) (69)
- Bone Turnover and Growth During and After Continuing Chemotherapy in Children with Acute Lymphoblastic Leukemia (2000) (69)
- In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade. (2001) (68)
- Recommendations for Diagnosis, Treatment, and Management of Individuals with Turner Syndrome (1994) (68)
- The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose. (2003) (68)
- Major Determinants of Height Development in Turner Syndrome (TS) Patients Treated With GH: Analysis of 987 Patients From KIGS (2007) (68)
- Continuous rise in incidence of childhood Type 1 diabetes in Germany (2008) (67)
- Interpretation of growth hormone provocative tests: comparison of cut-off values in four European laboratories. (1995) (64)
- Recurrence of brain tumours in patients treated with growth hormone: Analysis of KIGS (Pfizer International Growth Database) (2006) (63)
- IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T. (2006) (63)
- Magnetic resonance imaging of CNS in 15,043 children with GH deficiency in KIGS (Pfizer International Growth Database). (2013) (62)
- 17alpha-hydroxylase/17,20-lyase deficiency as a model to study enzymatic activity regulation: role of phosphorylation. (2000) (62)
- Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance (2005) (61)
- [Reduced incidence of side-effects of growth hormone substitution in 404 patients with hypophyseal insufficiency. Results of a multicenter indications study]. (1998) (61)
- Nested polymerase chain reaction study of 53 cases with Turner's syndrome: is cytogenetically undetected Y mosaicism common? (1995) (61)
- Spontaneous growth in idiopathic short stature. European Study Group. (1996) (60)
- Clinical and Endocrine Characteristics in Atypical and Classical Growth Hormone Insensitivity Syndrome (2001) (59)
- Height at Start, First-Year Growth Response and Cause of Shortness at Birth Are Major Determinants of Adult Height Outcomes of Short Children Born Small for Gestational Age and Silver-Russell Syndrome Treated with Growth Hormone: Analysis of Data from KIGS (2010) (58)
- Circadian patterns of serum insulin-like growth factor (IGF) II and IGF binding protein 3 in growth hormone-deficient patients and age- and sex-matched normal subjects. (1990) (57)
- Spontaneous adult height in idiopathic short stature. (1995) (56)
- Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study. (2000) (56)
- Outcome in tall stature. Final height and psychological aspects in 220 patients with and without treatment (1997) (55)
- IGF-II serum levels are normal in children with Silver-Russell syndrome who frequently carry epimutations at the IGF2 locus. (2006) (54)
- Variety in Growth Hormone Determinations due to Use of Different Immunoassays and to the Interference of Growth Hormone-Binding Protein (1999) (54)
- Observed and Predicted Total Pubertal Growth during Treatment with Growth Hormone in Adolescents with Idiopathic Growth Hormone Deficiency, Turner Syndrome, Short Stature, Born Small for Gestational Age and Idiopathic Short Stature: KIGS Analysis and Review (2011) (54)
- Adult height in Turner syndrome: results of a multinational survey 1993. (1994) (53)
- Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001. (2005) (53)
- Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis (1988) (53)
- Type 2 diabetes mellitus in children and adolescents is still a rare disease in Germany: a population‐based assessment of the prevalence of type 2 diabetes and MODY in patients aged 0–20 years (2009) (52)
- Should We Treat Children with Idiopathic Short Stature? (1999) (52)
- Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition. (2008) (51)
- Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries. (1995) (51)
- IGF1, IGF1R and SHOX Mutation Analysis in Short Children Born Small for Gestational Age and Short Children with Normal Birth Size (Idiopathic Short Stature) (2012) (50)
- Pilot Study of Elevated Levels of Insulin-Like Growth Factor-Binding Protein-2 as Indicators of Hepatocellular Carcinoma (2003) (50)
- (Epi)mutations in 11p15 significantly contribute to Silver-Russell syndrome: but are they generally involved in growth retardation? (2006) (50)
- GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism (2007) (49)
- Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS. (2005) (49)
- In VivoExpression of Insulin-Like Growth Factor-Binding Protein-2 in Human Gliomas Increases with the Tumor Grade. (2001) (48)
- Clinical relevance of serum measurements of insulin-like growth factors and somatomedin binding proteins. (1988) (48)
- Insulin-like growth factor binding protein 2 is differentially expressed in leukaemic B- and T-cell lines. (1996) (48)
- Isolation and partial characterization of six somatomedin-like peptides from human plasma Cohn fraction IV. (1986) (48)
- Isolated GH deficiency (IGHD) type II: imaging of the pituitary gland by magnetic resonance reveals characteristic differences in comparison with severe IGHD of unknown origin. (2002) (48)
- Homozygosity of the d3‐growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome (2008) (47)
- Central reassessment of GH concentrations measured at local treatment centers in children with impaired growth: consequences for patient management. (2004) (46)
- Diabetes incidence in children of different nationalities: an epidemiological approach to the pathogenesis of diabetes (2001) (46)
- Sex differences in binding of human growth hormone to isolated rat hepatocytes. (1976) (46)
- Varying clinical presentations at onset of type 1 diabetes mellitus in children – epidemiological evidence for different subtypes of the disease? (2001) (46)
- Brightness matching and colour discrimination in young diabetics without retinopathy (1994) (46)
- Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred. (2005) (46)
- Towards Optimal Treatment with Growth Hormone in Short Children and Adolescents: Evidence and Theses (2013) (45)
- Similar effects of long-term exogenous growth hormone (GH) on bone and muscle parameters: a pQCT study of GH-deficient and small-for-gestational-age (SGA) children. (2007) (44)
- Functional Endocrinologic Diagnostics in Children and Adolescents (1992) (44)
- Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial. (2009) (43)
- The effects of cyproterone acetate on statural growth in children with precocious puberty. (1987) (43)
- The somatotrophic system in patients with dilated cardiomyopathy: Relation of insulin‐like growth factor‐1 and its alterations during growth hormone therapy to cardiac function (2000) (42)
- Automatic Determination of Left- and Right-Hand Bone Age in the First Zurich Longitudinal Study (2010) (42)
- The Kabi Pharmacia International Growth Study: Aetiology Classification List with Comments (1991) (40)
- Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pfizer International Growth Database) (2011) (39)
- Baseline Characteristics and Gender Differences in Prepubertal Children Treated with Growth Hormone in Europe, USA, and Japan: 25 Years' KIGS® Experience (1987-2012) and Review (2016) (39)
- Diagnosis of Growth Hormone Deficiency and Growth Hormone Stimulation Tests (2003) (39)
- How Should Insulin-Like Growth Factor I Be Measured? (2004) (38)
- Insulin Tolerance Test Causes Hypokalaemia and Can Provoke Cardiac Arrhythmias (2004) (38)
- Spontaneous Growth in Turner's Syndrome (1988) (38)
- Rising incidence of type 1 diabetes in Germany: 12-year trend analysis in children 0-14 years of age. (2001) (38)
- Growth Hormone Treatment in Dilated Cardiomyopathy (2001) (37)
- Growth During the First Two Years Predicts Pre-School Height in Children Born With Very Low Birth Weight (VLBW): Results of a Study of 1,320 Children in Germany (2007) (37)
- Paternally inherited deletion of CSH1 in a patient with Silver-Russell syndrome. (1998) (37)
- Insulin-like growth factors and their binding proteins in patients with growth hormone receptor deficiency: suggestions for new diagnostic criteria. The Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes. (1992) (36)
- 5 Recombinant human growth hormone (1986) (36)
- Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults. (2008) (36)
- Limited Proteolysis of the IGF Binding Protein-2 (IGFBP-2) by a Specific Serine Protease Activity in Early Breast Milk (1999) (36)
- Experience with Growth Hormone Therapy in Turner Syndrome in a Single Centre: Low Total Height Gain, No Further Gains after Puberty Onset and Unchanged Body Proportions (2000) (36)
- Predicting the response to growth hormone treatment in short children with chronic kidney disease. (2010) (36)
- Treatment of children and adolescents with idiopathic short stature (2013) (36)
- Formation of uniparental disomy 7 delineated from new cases and a UPD7 case after trisomy 7 rescue. Presentation of own results and review of the literature. (2000) (35)
- Insulin-Like Growth Factors and Binding Proteins in Early Milk from Mothers of Preterm and Term Infants (2007) (35)
- IGF-I and IGF Binding Protein-3 Levels during Initial GH Dosage Step-Up Are Indicators of GH Sensitivity in GH-Deficient Children and Short Children Born Small for Gestational Age (2005) (34)
- The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults. (2002) (34)
- Schoolchildren born VLBW or VLGA show height-related changes in body composition and muscle function but no evidence of metabolic syndrome risk factors. Results from the NEOLONG study (2016) (34)
- Cortical bone density is normal in prepubertal children with growth hormone (GH) deficiency, but initially decreases during GH replacement due to early bone remodeling. (2004) (34)
- Elevated insulin-like growth factor (IGF) binding protein (IGFBP)-2 and IGFBP-4 expression of leukemic T-cells is affected by autocrine/paracrine IGF-II action but not by IGF type I receptor expression. (1998) (34)
- Reference Levels of Insulin-Like Growth Factor I in the Serum of Healthy Adults: Comparison of Four Immunoassays (2003) (34)
- Association between Head Circumference and Body Size (2011) (34)
- Consensus on How to Measure Growth Hormone in Serum (1999) (33)
- Incidence of diabetes mellitus among children of Italian migrants substantiates the role of genetic factors in the pathogenesis of type 1 diabetes (2009) (33)
- Radiological Signs of Leri-Weill Dyschondrosteosis in Turner Syndrome (2001) (33)
- Insulin-like growth factor binding proteins (IGFBPs) with special reference to IGFBP-3. (1990) (33)
- Validation of Bone Age Methods by Their Ability to Predict Adult Height (2010) (32)
- Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database). (2010) (32)
- The metabolic effects of short‐term administration of physiological versus high doses of GH therapy in GH deficient adults (2002) (32)
- Late effects after stem cell transplantation (SCT) in children – growth and hormones (2005) (31)
- Conflicting reports of imprinting status of human GRB10 in developing brain: how reliable are somatic cell hybrids for predicting allelic origin of expression? (2001) (31)
- Effects of a third intensification block of chemotherapy on bone and collagen turnover, insulin-like growth factor I, its binding proteins and short-term growth in children with acute lymphoblastic leukaemia. (1999) (30)
- Validation of automatic bone age rating in children with precocious and early puberty (2011) (30)
- IGFs and IGFBPs in GH insensitivity. (2005) (29)
- Insulin-like growth factors and their binding proteins in human follicular fluid. (1991) (29)
- The early dehydroepiandrosterone sulfate rise of adrenarche and the delay of pubarche indicate primary ovarian failure in Turner syndrome. (2004) (29)
- X-linked congenital adrenal hypoplasia: new mutations and long-term follow-up in three patients. (2000) (29)
- A note on adults with growth hormone deficiency. (1987) (28)
- Plasma Adrenocorticotropin, Cortisol, and Dehydroepiandrosterone Response to Corticotropin-Releasing Factor in Normal Children during Pubertal Development (1987) (28)
- Metacarpal thickness, width, length and medullary diameter in children—reference curves from the First Zürich Longitudinal Study (2011) (28)
- Turner syndrome in a life span perspective : research and clinical aspects : proceedings of the 4th International Symposium on Turner Syndrome, Gothenburg, Sweden, 18-21 May, 1995 (1995) (26)
- Insulin-Like Growth Factors as Diagnostic Tools in Growth Hormone Deficiency during Childhood and Adolescence: The KIGS Experience (2005) (26)
- Disease‐Specific Growth Charts — Do We Need Them? (1989) (26)
- Final Height in Children with Medulloblastoma Treated with Growth Hormone (2005) (25)
- Catch-Up Growth after Childhood-Onset Substitution in Primary Hypothyroidism: Is It a Guide towards Optimal Growth Hormone Treatment in Idiopathic Growth Hormone Deficiency? (1998) (25)
- Insulin-like growth factor I accelerates gastric ulcer healing by stimulating cell proliferation and by inhibiting gastric acid secretion. (2001) (25)
- Early-Onset Idiopathic Growth Hormone Deficiency within KIGS (2003) (25)
- Defining Insulin-Like Growth Factor-I Deficiency (2006) (25)
- MR imaging and spectroscopy of a tuber cinereum hamartoma in a patient with growth hormone deficiency and hypogonadotropic hypogonadism. (2003) (25)
- Validation of automatic bone age determination in children with congenital adrenal hyperplasia (2013) (25)
- Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy, 27-28 March 1998. (1998) (25)
- Screening for Mutations in the Promoter and the Coding Region of the IGFBP1 and IGFBP3 Genes in Silver-Russell Syndrome Patients (1999) (25)
- Role of nitric oxide in the vasodilator effect of recombinant human growth hormone in patients with dilated cardiomyopathy. (2000) (24)
- Copy Number Variants in Short Children Born Small for Gestational Age (2014) (24)
- Human growth hormone measurement by means of a sensitive ELISA of whole blood spots on filter paper. (2008) (23)
- Accurate Long-Term Prediction of Height during the First Four Years of Growth Hormone Treatment in Prepubertal Children with Growth Hormone Deficiency or Turner Syndrome (2012) (23)
- Growth Hormone Deficiency: Diagnostic Principles and Practice (2011) (23)
- Dosing of Growth Hormone in Growth Hormone Deficiency (1999) (22)
- Measuring IGF-I, IGFBP-2 and IGFBP-3 from dried blood spots on filter paper is not only practical but also reliable. (2003) (22)
- Pseudopituitary dwarfism due to resistance to somatomedin: A new syndrome (1984) (22)
- Improvement of uremic growth failure by recombinant human growth hormone. (1989) (22)
- Transactivation of the IGFBP-2 promoter in human tumor cell lines (2001) (22)
- Experimental ischemic wounds: Correlation of cell proliferation and insulin‐like growth factor I expression and its modification by different local IGF‐I release systems (2005) (22)
- The Potential of Prediction Models Based on Data from KIGS as Tools to Measure Responsiveness to Growth Hormone (2004) (21)
- Bone Turnover and Growth during and after Chemotherapy in Children with Solid Tumors (2004) (21)
- Tall stature, gonadal dysgenesis, and stigmata of Turner's syndrome caused by a structurally altered X chromosome. (2001) (21)
- Growth hormone binding protein levels in children are associated with birth weight, postnatal weight gain, and insulin secretion. (2007) (21)
- Measurement of immunofunctional leptin to detect and monitor patients with functional leptin deficiency (2016) (21)
- Plasma Concentrations of the Carboxyterminal Propeptide of Type I Procollagen (PICP) in Preterm Neonates from Birth to Term (2000) (20)
- Effects of growth hormone on the metabolism of lipids and water and their potential in causing adverse events during growth hormone treatment. (1993) (20)
- 4 Treatment of growth hormone deficiency (1986) (20)
- Treatment of dwarfism with recombinant human insulin-like growth factor-1. (2009) (20)
- New Preparations Comprising Recombinant Human Growth Hormone: Deliberations on the Issue of Biosimilars (2007) (20)
- Automation of Bone Age Reading and a New Prediction Model Improve Adult Height Prediction in Children with Short Stature (2013) (20)
- Characterization of genomic variants in CSH1 and GH2, two candidate genes for Silver-Russell syndrome in 17q24-q25. (2003) (20)
- Growth hormone therapy in children: when to stop? (1995) (19)
- Growth Hormone Therapy in Turner Syndrome (1995) (19)
- Eating Disorder Pathology in Adolescents Participating in a Lifestyle Intervention for Obesity: Associations with Weight Change, General Psychopathology and Health-Related Quality of Life (2013) (19)
- Noonan Syndrome: Genetics and Responsiveness to Growth Hormone Therapy (2007) (19)
- Growth hormone treatment of idiopathic short stature: analysis of the database from KIGS, the Kabi Pharmacia International Growth Study (1994) (19)
- The KIGS Experience with the Addition of Gonadotropin-Releasing Hormone Agonists to Growth Hormone (GH) Treatment of Children with Idiopathic GH Deficiency (2003) (19)
- Treatment with Growth Hormone in Noonan Syndrome Observed during 25 Years of KIGS: Near Adult Height and Outcome Prediction (2019) (19)
- Treatment of growth hormone insensitivity syndrome (GHIS) with insulin-like growth factor (IGF-I). (1996) (19)
- Clinical Experience with Authentic Recombinant Somatropin – German Collaborative Study (1987) (19)
- Clinical considerations in using growth hormone therapy in growth hormone deficiency. (2010) (18)
- The Early Dehydroepiandrosterone Sulfate Rise of Adrenarche and the Delay of Pubarche Indicate Primary Ovarian Failure in Turner Syndrome (2004) (18)
- Immunoreactive insulin-like growth factor binding protein-3 in the culture of human luteinized granulosa cells. (1991) (18)
- Metabolic effects of growth hormone in children. (1995) (17)
- Growth Hormone Treatment of Short Stature State‐of‐the‐art 1989 (1989) (17)
- KIGS and KIMS as Tools for Evidence-Based Medicine (1999) (17)
- Screening for Insulin-like Growth Factor-I Receptor Mutations in Patients with Silver-Russell Syndrome (2002) (17)
- Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormone (2017) (17)
- Standardization of the Tanner-Whitehouse bone age method in the context of automated image analysis (2012) (17)
- Dose-dependent responses in insulin-like growth factors, insulin-like growth factor-binding protein-3 and parameters of bone metabolism to growth hormone therapy in young adults with growth hormone deficiency. (1995) (17)
- Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma. (2006) (17)
- No evidence for isolated imprinting mutations in the PEG1/MEST locus in Silver-Russell patients. (2008) (16)
- Total Pubertal Growth and Markers of Puberty Onset in Adolescents with GHD: Comparison between Mathematical Growth Analysis and Pubertal Staging Methods (2005) (16)
- Insulin-like growth factor-binding proteins 2 and 3 are independent predictors of a poor prognosis in patients with dilated cardiomyopathy (2007) (16)
- Effect on growth of patients with Turner's syndrome treated with low estrogen doses. (1986) (16)
- Central laboratory reassessment of IGF-I, IGF-binding protein-3, and GH serum concentrations measured at local treatment centers in growth-impaired children: implications for the agreement between outpatient screening and the results of somatotropic axis functional testing. (2007) (16)
- Biparental expression of IGFBP1 and IGFBP3 renders their involvement in the etiology of Silver-Russell syndrome unlikely. (1999) (16)
- Serpentine fibula — polycystic kidney syndrome and Melnick-Needles syndrome are different disorders (1993) (16)
- Association Analysis of Ten Candidate Genes in a Large Multinational Cohort of Small for Gestational Age Children and Children with Idiopathic Short Stature (NESTEGG study) (2013) (15)
- Metacarpal thickness, width, length and medullary diameter in children — Reference curves from the first Zürich longitudinal study (2009) (15)
- Secretion of Noncomplexed ‘Big’ (10–18 kD) Forms of Insulin-Like Growth Factor-II by 12 Soft Tissue Sarcoma Cell Lines (2000) (15)
- Idiopathic Growth Hormone Deficiency in KIGS: Selected Aspects (2007) (15)
- [Constitutional development retardation: a simple variant of normal growth?]. (1982) (15)
- Growth and Development are Similar in VLBW Children Born Appropriate and Small for Gestational Age: An Interim Report on 97 Preschool Children (2007) (15)
- Is there a medical need to explore the clinical use of insulin-like growth factor I? (2001) (15)
- The Ethical Dilemma of Growth Hormone Treatment of Short Stature: A Scientific Theoretical Approach (1999) (15)
- Gene dosage analysis in Silver-Russell syndrome: use of quantitative competitive PCR and dual-color FISH to estimate the frequency of duplications in 7p11.2-p13. (2001) (15)
- Structural analysis of human growth hormone with respect to the dominant expression of growth hormone (GH) mutations in isolated GH deficiency type II. (2005) (14)
- Variants of the FTO gene in obese children and their impact on body composition and metabolism before and after lifestyle intervention. (2012) (14)
- Data Analyses within KIGS (2007) (14)
- Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients (2020) (14)
- The Basis for Optimising Growth with Growth Hormone Usage in Children with Idiopathic Short Stature: Analysis of Data from KIGS (Pfizer International Growth Study Database) (2011) (14)
- Height, Muscle, Fat and Bone Response to Growth Hormone in Short Children with Very Low Birth Weight Born Appropriate for Gestational Age and Small for Gestational Age (2014) (14)
- Testing with growth hormone-releasing factor (GRF(1–29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency (1986) (14)
- Safety of human growth hormone therapy. (1993) (14)
- Investigation of myostatin serum levels before and after a 6-month lifestyle intervention program in obese children. (2010) (14)
- Different relationships between the first 2 years on growth hormone treatment and the d3‐growth hormone receptor polymorphism in short small‐for‐gestational‐age (SGA) children (2011) (14)
- Analyses from a Centre of Short- and Long-Term Growth in Turner’s Syndrome on Standard Growth Hormone Doses Confirm Growth Prediction Algorithms and Show Normal IGF-I Levels (2012) (13)
- Mixed Gonadal Dysgenesis and Precocious Puberty (2002) (13)
- IGFs, IGFBPs, IGF-Binding Sites and Biochemical Markers of Bone Metabolism during Differentiation in Human Pulp Fibroblasts (2004) (13)
- Is growth hormone treatment in children associated with weight gain? – Longitudinal analysis of KIGS data (2014) (13)
- Is maternal duplication of 11 p 15 associated with Silver-Russell syndrome ? (2005) (13)
- New Paradigms for Growth Hormone Treatment in the 21st Century: Prediction Models (2000) (13)
- The Auxological and Biochemical Continuum of Short Children Born Small for Gestational Age (SGA) or with Normal Birth Size (Idiopathic Short Stature) (2010) (12)
- A Genome-Wide Pharmacogenetic Study of Growth Hormone Responsiveness (2020) (12)
- The polymorphic pattern of somatomedins during human development. (1987) (12)
- Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS). (1999) (12)
- Disease-specific standards in congenital syndromes. (1996) (12)
- Growth Hormone-Induced Increases in Skeletal Muscle Mass Alleviates the Associated Insulin Resistance in Short Children Born Small for Gestational Age, but Not with Growth Hormone Deficiency (2009) (12)
- Adult Height in Children with Constitutional Short Stature (1989) (11)
- Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II). (2007) (11)
- Implications of a Data-Driven Approach to Treatment with Growth Hormone in Children with Growth Hormone Deficiency and Turner Syndrome (2013) (11)
- De novo mutations of the growth hormone gene: an important cause of congenital isolated growth hormone deficiency? (1998) (11)
- THERAPEUTIC RESPONSE TO RECOMBINANT IGF-1 IN THIRTY TWO PATIENTS WITH GROWTH HORMONE INSENSITIVITY (1993) (11)
- The functional muscle-bone unit in obese children - altered bone structure leads to normal strength strain index. (2011) (11)
- Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients. (1993) (11)
- Long-term response to human growth hormone in 36 children with idiopathic growth hormone deficiency (2004) (11)
- [Adrenocortical nodular hyperplasia as a cause of Cushing syndrome in the neonatal period]. (1991) (10)
- IRS1 and GRB2 as members of the IGF signal transduction pathway are not associated with intrauterine growth retardation and Silver–Russell syndrome (2001) (10)
- Prediction Model of Total Pubertal Growth in Idiopathic Growth Hormone Deficiency: Analysis of Data from KIGS (2003) (10)
- Randomized, double-blind, placebo-controlled trial of growth hormone in patients with dilated cardiomyopathy (1998) (10)
- Spontaneous growth and bone age development in a patient with 17alpha-hydroxylase deficiency: evidence of the role of sexual steroids in prepubertal bone maturation. (1999) (10)
- Alu-Mediated Recombination Defect in IGF1R: Haploinsufficiency in a Patient with Short Stature (2013) (10)
- The Marfan syndrome —analysis of growth and cardiovascular manifestation (1990) (10)
- Height Gain in Ullrich-Turner Syndrome after Early and Late Growth Hormone Treatment Start: Results from a Large Retrospective German Study and Potential Basis for an Individualized Treatment Approach (2013) (10)
- Exclusion of a disease relevant role of PAX4 in the aetiology of Silver-Russell syndrome: screening for mutations and determination of imprinting status (2000) (10)
- The KIGS Aetiology Classification System (2007) (9)
- A rapid screening for steroid 21‐hydroxylase mutations in patients with congenital adrenal hyperplasia (1999) (9)
- Growth hormone treatment in short children born small for gestational age: from controversy towards consensus. (1997) (9)
- Prevalence and incidence of endocrine disorders in children: results of a survey in Baden-Wuerttemberg and Bavaria (EndoPrIn BB) 2000-2001. (2010) (9)
- Comparison of radiogrammetrical metacarpal indices in children and reference data from the First Zurich Longitudinal Study (2012) (9)
- Adult Height Prediction Models (2012) (9)
- Basal characteristics and first year responses to human growth hormone (GH) vary according to diagnostic criteria in children with non-acquired GH deficiency (naGHD): observations from a single center over a period of five decades (2018) (8)
- Bell's palsy after onset of insulin‐like growth factor I therapy in a patient with growth hormone receptor deficiency (1994) (8)
- LOT1 (ZAC1/PLAGL1) as Member of an Imprinted Gene Network Does Not Harbor Silver-Russell Specific Variants (2009) (8)
- Approach to predicting the growth response during growth hormone treatment (1996) (8)
- Transient Pseudohypoaldosteronism with Complex Malformation of Internal Genitalia (2001) (8)
- Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency (2021) (8)
- Growth in Turner's syndrome (1994) (8)
- Why Treat girls with Turner Syndrome with Growth Hormone? Growth and Beyond. (2015) (8)
- Responsiveness of cortisol and dehydroepiandrosterone to ACTH in children. (1982) (8)
- Cerebral gigantism of hypothalamic origin (1983) (8)
- Mutant and Misfolded Human Growth Hormone is Rapidly Degraded Through the Proteasomal Degradation Pathway in a Cellular Model for Isolated Growth Hormone Deficiency Type II (2007) (8)
- Short Children with Low Birth Weight Born either Small for Gestational Age or Average for Gestational Age Show Similar Growth Response and Changes in Insulin-Like Growth Factor-1 to Growth Hormone Treatment during the First Prepubertal Year (2011) (8)
- OVERWEIGHT AND OBESITY (2007) (7)
- Noonan Syndrome: Growth to Growth Hormone – The Experience of Observational Studies (2009) (7)
- Growth hormone therapy in Turner syndrome. Analysis of long-term results. (1995) (7)
- Current Concepts in the Treatment of Turner Syndrome with Special Reference to the Treatment of Short Stature (1992) (7)
- Decreased expression of IGF-II and its binding protein, IGF-binding protein-2, in genital skin fibroblasts of patients with complete androgen insensitivity syndrome compared with normally virilized males. (2001) (7)
- Growth disorder in the Ullrich-Turner syndrome. (1992) (6)
- A growth prediction model for short children born small for gestational age. (2002) (6)
- DISORDERS OF SEX DEVELOPMENT (DSD) (2007) (6)
- Clinical experience with authentic recombinant human growth hormone. (1986) (6)
- Application of a solid-phase radioimmunoassay and immune electron microscopy for hepatitis A in diagnosis and research (1978) (6)
- Segmental uniparental disomy of 7q31‐qter is rare in Silver–Russell syndrome (2001) (6)
- [Considerations of growth hormone treatment during the transition from adolescence to adulthood]. (2009) (6)
- Validation of functional insulin-like growth factor binding protein-3 measurement by a ligand immunoassay. (2010) (6)
- 8 Growth disorder in the Ullrich—Turner syndrome (1992) (6)
- Relative leptin deficiency in children with severe early-onset obesity (SEOO) – results of the Early-onset Obesity and Leptin – German-Polish Study (EOL-GPS) (2020) (6)
- Accuracy and self-validation of automated bone age determination (2022) (5)
- Changes in whole-body fat distribution, intrahepatic lipids, and insulin resistance of obese adolescents during a low-level lifestyle intervention (2015) (5)
- Treatment with Recombinant Human Insulin-Like Growth Factor-1 in Severe Primary IGF Deficiency and Beyond (2015) (5)
- Turner Syndrome within KIGS Including an Analysis of 1146 Patients Grown to Near Adult Height (2007) (5)
- Pediatric Growth Hormone Deficiency (GHD) in the Recombinant Human GH (rhGH) Era. (2018) (5)
- In vitro analysis of hGH secretion in the presence of mutations of amino acids involved in zinc binding. (2007) (5)
- Chairman’s Summary: Definition of Idiopathic Short Stature (2011) (5)
- IGFBP-2/IGF-I/Proteoglycan complexes in the rat brain olfactory bulb (2004) (5)
- Correlation of type I insulin-like growth factor receptor (IGF-I-R) and insulin receptor-related receptor (IRR) messenger RNA levels in tumor cell lines from pediatric tumors of neuronal origin (1999) (5)
- Influence of IGF-I and Cell Density on MDR1 Expression in the T-Lymphoblastoid Cell Line CCRF-CEM (2000) (5)
- Catch-up growth: new lessons for the clinician. (2002) (5)
- Normal-Weight 14-Year-Old Girl with Acanthosis Nigricans and Markedly Increased Hepatic Steatosis: Evidence for the Important Role of Ectopic Fat Deposition in the Pathogenesis of Insulin Resistance in Childhood and Adolescence (2010) (5)
- Sensitivity to IGF-I in short children born small for gestational age. (2006) (5)
- Acromegaly and end-stage renal disease: A diagnostic challenge (2006) (5)
- 16 YEARS OF NORMAL GROWTH WITHOUT GROWTH HORMONE(GH), WITHOUT IGF-I AND IGFBP-3 AND WITHOUT OBESITY (1993) (5)
- KIGS: 20 Years (2007) (4)
- Genital Skin Fibroblasts (GF) of Patients with Androgen Insensitivity Syndrome Express Higher Insulin-Like Growth Factor Binding Protein (IGFBP)-2, -3 and -5 than GF of Normally Virilized Males (2003) (4)
- Thyroid Function in Healthy and Sick Preterm Infants: Changes in TSH, T4, fT4 and T3 from Day 1 to 12 (2007) (4)
- Important Tools for Use by Pediatric Endocrinologists in the Assessment of Short Stature (2020) (4)
- Growth hormone in Turner syndrome (2001) (4)
- Isolation of acid-stable insulin-like growth factor binding protein from human plasma Cohn fraction IV (1988) (4)
- Left middle finger metacarpophalangeal growth in Turner syndrome. Normal values and changes after growth hormone treatment. (1991) (4)
- Differentiation of GH effects on metacarpal bone in children with GHD (2009) (4)
- Prediction of response to Gh: does it help to individualize therapy? (1999) (4)
- Diagnostic Proceeding in Silver-Russell Syndrome (2012) (4)
- Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL) (2021) (4)
- Children with acute Perthes' disease have asymmetrical lower leg growth and abnormal collagen turnover (2005) (4)
- Improvement of Growth by Recombinant Human Growth Hormone in Uraemic Children (1989) (4)
- Reflections on the US Guidelines on Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents (2016) (4)
- Subject Index Vol. 44, 1995 (1995) (4)
- Decreased insulin-like growth factors 1 and 2 in sera of patients with osteoporosis (1992) (4)
- SYNDROMES WITH ENDOCRINE FEATURES (2007) (4)
- Comprar Diagnostics of endocrine function in children and adolescents | M. B. Ranke | 9783805594141 | Karger AG (2011) (3)
- Treatment of growth hormone deficiency. (1986) (3)
- Stunted growth due to peripheral resistance to somatomedin, a new syndrom (1981) (3)
- Search for subtelomeric imbalances by multiplex ligation-dependent probe amplification in Silver-Russell syndrome. (2008) (3)
- Clinical experience with GRF. (1986) (3)
- Predicting Growth in Response to Growth Hormone Treatment – The KIGS Approach (2007) (3)
- Conclusions: a consensus statement on growth hormone therapy. (1990) (3)
- Turner and Noonan syndromes: Disease-specific growth and growth- promoting therapies (2007) (3)
- Human growth hormone therapy of non-growth hormone deficient children. (1987) (3)
- Insulin-Like Growth Factor 1 Levels in Patients within the KIGS Database (2007) (3)
- Introduction of New Recombinant Insulin-like Growth Factor-1 – Current and Future Perspectives (2008) (2)
- Kidney disease and thyroid dysfunction: the chicken or egg problem (2022) (2)
- Increased insulin-like growth factor-II tissue concentrations during compensatory kidney growth in infantile rats (1992) (2)
- Contents / Contributors / Preface (2007) (2)
- Short- and Long-Term Response to Growth Hormone in Idiopathic Short Stature : KIGS Analysis of Factors Predicting Growth (2007) (2)
- Estrogens promote growth: Experimental and clinical evidence (1984) (2)
- Determinants for body image and coping inpatients with Turner syndrome (2000) (2)
- [Therapy of pituitary dwarfism with recombinant human growth hormone. A multicenter study]. (1986) (2)
- Who Stops Growth Hormone in KIGS – and Why? (2007) (2)
- OVARIES, FEMALE REPRODUCTIVE TRACT AND BREASTS (2007) (2)
- Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort (2022) (2)
- Turner Syndrome: Growth Promoting Therapies : Proceedings of a Workshop on Turner Syndrome, Frankfurt/Main, 25-26 May 1990 (1991) (2)
- Amniotic fluid levels of 17 alpha-hydroxyprogesterone during human pregnancy: pre-natal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. (1982) (2)
- The Physiology of Insulin-like Growth Factor Binding Protein-3 and Its Role in Disorders of the Growth Hormone Axis (1993) (2)
- Modalities and Characteristics at Birth: Commentaries Based on KIGS Data (2007) (2)
- Central laboratory reassessment of IGF-I, IGFBP-3 and GH serum concentrations measured at local treatment centers in growth-impaired children: implications for the agreement between outpatient screening and the results of somatotropic axis functional testing (2007) (2)
- A Proposal to Develop New References for Serum IGF-I Levels in Children (2020) (2)
- NESTEGG: aims and strategies. Northern European Study of Genes in Growth. (2002) (2)
- Stunted growth with more or less normal appearance (1982) (2)
- Skeletal Muscle as a Response Target: The Link between Growth and Metabolism (2007) (1)
- Unusual course of a chlamydia pneumonia in an infant with IgG2/IgG4-deficiency (1989) (1)
- 110 SOMATOMEDINS POTENTIATE INTERLEUKIN 2 INDUCED STIMULATION OF NATURAL KILLER CELL ACTIVITY (1988) (1)
- SOMATOMEDINS AND GROWTH HORMONE (GH) SECRETION IN ULLRICH-TURNER SYNDROME (UTS) (1988) (1)
- Reply to Rosenbloom (2012) (1)
- Cross-talk between IGFBPs and integrin receptors: Implications for IGFBP function (2002) (1)
- Short stature in children—diagnostic and therapeutical problems (1991) (1)
- Prediction of Adult Height in Turner Syndrome (1994) (1)
- [Alteration of TSH secretion in children with goitre after short-term treatment with potassium iodide (author's transl)]. (1979) (1)
- NESTEGG: Aims and strategies (2002) (1)
- SHORT STATURE (2007) (1)
- Introduction: Thyroid Function and Thyroid Therapy in the Premature Infant (2007) (1)
- 31 SOMATOMEDIN BINDING PROTEIN (SmBP) IN NORMALS AND IN GROWTH HORMONE DEFICIENCY (GHD) (1988) (1)
- A longitudinal study of the effects of SRIF on growth and peripheral hormones in the male rat during pubertal developmant (1981) (1)
- Longitudinal analysis of virus load, serum antibody levels and virus neutralizing activity in vitro in cases with less severe COVID-19 (2020) (1)
- Analysis of Components of the Growth Hormone (GH) Axis in (GH Deficient) Patients with Silver-Russell Syndrome (2002) (1)
- Subject Index Vol. 64, Suppl. 3, 2005 (2006) (1)
- The Role of IGF Parameters in the Management of Growth Disorders and Acromegaly - Diagnosis, Efficacy and Safety: 7th KIGS/KIMS Expert Meeting on Growth Hormone and Growth Disorders, Paris, January 2004 (2005) (1)
- Gas-liquid chromatography in the diagnosis of congenital adrenal hyperplasia. (1974) (1)
- PEDICTION OF ADULT HEIGHT IN TURNER SYNDROME (1993) (1)
- Approaches to the evaluation of growth and growth disorders in children after bone marrow transplantation (BMT). (1991) (1)
- KIGS Patients with Acquired Growth Hormone Deficiency (Code No. 2.2 ff.) (2007) (1)
- CHANGING RESPONSIVENESS OF DHA TO ACTH (1981) (1)
- Network of European Studies of Genes in Growth (NESTEGG) (2009) (1)
- The use of ghrh in pediatrics (1989) (1)
- The effect of glibenclamide on plasma insulin, plasma somatomedin bioactivity and skeletal growth in hypophysectomized rats. (1982) (1)
- Recombinant human growth hormone. (1986) (1)
- Proper gender assignment in indeterminate cases was one of the issues entailing the greatest responsibility in our field. (2001) (1)
- THYROTROPIN RELEASING HORMONE-INDUCED TSH RESPONSE IN CHILDREN WITH PRIMARY CONGENITAL HYPOTHYROIDISM UNDER TREATMENT (1974) (1)
- 46 USE OF GRF(1–29) FOR GROWTH HORMONE STIMULATION (1985) (1)
- Differential expression of insulin-like growth factor binding proteins in T- and B-cells, activated versus non-activated and mature versus immature lymphoid cells (1997) (0)
- 47 EFFECT OF CHRONIC GRF ADMINISTRATION ON MALE RATS DURING PUBERTAL DEVELOPMENT (1985) (0)
- The Handbook of Growth and Growth Monitoring in Health and Disease Springer ( c ) Nov 2009 (2009) (0)
- Mutation and Polymorphism Report (2000) (0)
- Subject Index Vol. 67, Suppl. 1, 2007 (2007) (0)
- Growth Hormone and Endocrinology: 14th Novo Nordisk Symposium and SGA Satellite Symposium, Estoril/Lisbon, March 2003: Proceedings (2003) (0)
- Growth Standards, Bone Maturation and Idiopathic Short Stature: 1st KIGS Expert Meeting on Growth and Growth Disorders, Positano, Italy, November 1995 (1996) (0)
- Growth Hormone Deficiency of Known Origin within KIGS (Code No. 2.1.1–2.1.6) (2007) (0)
- Sequential Application of Annual Prediction Models Permits Accurate Simulation of Height Development during Long-Term Growth Hormone (GH) Treatment in Prepubertal Children with Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) (2011) (0)
- Increased mortality associated with growth hormone treatment in critically ill adults. (2000) (0)
- Subject Index Vol. 76, Suppl. 3, 2011 (2011) (0)
- Subject Index Vol. 43, 1995 (1995) (0)
- Preface (2005) (0)
- Subject Index Vol. 43, 1995 (1995) (0)
- Relationship between growth and psychomotor development of preterm children (2012) (0)
- TESTICULAR DISORDERS/ DISORDERS OF MALE GENITALS (2007) (0)
- Subject Index Vol. 80, 2013 (2014) (0)
- Subject Index Vol. 80, 2013 (2014) (0)
- GHD during Critical Phases of Life: 6th KIGS/KIMS Expert Meeting on Growth Hormone and Growth Disorders, Florence, November 2002 (2003) (0)
- Standardization of Growth Hormone Measurement, Evidence-Based Medicine: 3rd KIGS/KIMS Expert Meeting on Growth and Growth Disorders, Sorrento, November 1998 (1999) (0)
- Sensitivity to Growth Hormone, Standardization of IGF-I Measurements: 5th KIGS/KIMS Expert Meeting on Growth and Growth Disorders, Windsor, February 2001 (2001) (0)
- Response to Classen and Classen (1997) (0)
- Response to Letter to the Editor: “A Genome-Wide Pharmacogenetic Study of Growth Hormone Responsiveness” (2020) (0)
- Detection and Diagnosis of Impaired Growth-Hormone Secretion - Discussion (1987) (0)
- hGH Symposium: 11th Symposium, Sorrento, March-April 2000 (2000) (0)
- Insulinlike Growth Factors (IGF-I, IGF-II) nach gastrointestinalen Eingriffen (1990) (0)
- On the 47 th Annual Meeting of the European Society For Paediatric Endocrinology ( ESPE ) – Istanbul , Turkey – 20-23 September 2008 (2008) (0)
- Novel silent variant (c1722G>A) in the coding region of the insulin receptor substrate 1 (IRS1) gene Communicated by: Mark H. Paalman Online Citation: Human Mutation, Mutation and Polymorphism Report #186 (2000) Online http://journals.wiley.com/1059-7794/pdf/mutation/mpr186.pdf Acknowledgments: This (2000) (0)
- Quality assurance in the analysis of growth hormone and insulin-like growth factor I in disorders of the somatotropic axis (2016) (0)
- The effect of the sulfonylurea glitenclamide on different growth parameters in hypophysectomized male rats (1979) (0)
- Content Vol. 51, 1999 (1999) (0)
- The tenth hGH symposium, Seville, April 23-24, 1999 (1999) (0)
- The Tenth hGH Symposium (2016) (0)
- Growth Hormone Insensitivity Syndrome (GHIS): Clinical Presentation and Effects of Treatment with Recombinant Human Insulin-like Growth Factor I (rhIGF-I) European Experience (1994) (0)
- Response to Letter to the Editor from Virú-Loza and Chávez-Nomberto: "Safety and efficacy of pediatric growth hormone therapy: Results from the full KIGS cohort". (2023) (0)
- Complexation to insulin-like growth factor (IGF) binding protein potentiates the mitogenic activity of IGF-I (1988) (0)
- THE POLYMORPHIC PATTERN OF SOMATOMEDINS DURING DEVELOPMENT (1986) (0)
- The 11th hGH Symposium, Sorrento, March 30-April 2, 2000 (2000) (0)
- Endocrine Disorders in Adolescence (2013) (0)
- The Effect of Growth Hormone (GH) Treatment on Forearm Muscle in GH-Deficient Children: Evidence Based on Peripheral Quantitative Computed Tomography Measurements (2007) (0)
- Contents Vol. 86, 2016 (2017) (0)
- Preface (2003) (0)
- [Growth hormone level during stimulation tests and efficacy of growth hormone therapy in children with growth hormone insufficiency and idiopathic short stature]. (1993) (0)
- Structural Analysis of Human Growth Hormone with Respect to the Dominant Expression of GH Mutations in Isolated Growth Hormone Deficiency Type II Inaugural (2005) (0)
- Individualised Growth Response Optimisation (IGRO): A Multi-Language Software Medical Device to Predict Growth Response in Children Treated With Growth Hormone (GH). (2014) (0)
- Normal Values of Circulating IGF-I Bioactivity in the Healthy Population: Comparison with five widely used IGF-I immunoassays (2008) (0)
- Title Page / Table of Contents / Preface / Preface to the Third Edition / Preface to the Second Edition / Preface to the First Edition / Before Using this Book (2011) (0)
- Sensitivity to Growth Hormone, Standardization of IGF-I Measurements. Proceedings of the 5th KIGS/KIMS Expert Meeting on Growth and Growth Disorders. Windsor, United Kingdom. February 2-3, 2001. (2001) (0)
- Insulin-like growth factors I and II potentiate the stimulatory effect of interleukin 2 on natural killer cell activity (1988) (0)
- Preface (2007) (0)
- Front & Back Matter (2012) (0)
- [Studies on glucose tolerance and plasma lipids in children and young adults with potential diabetes]. (1969) (0)
- TALL STATURE (2007) (0)
- Growth of infants born <32 weeks of gestation (2004) (0)
- 16th Workshop for Pediatric Research Abstracts (2004) (0)
- Acknowledgements to Reviewers (2003) (0)
- Growth standards, bone maturation and idiopathic short stature : 1st KIGS Expert Meeting, Positano, Italy, November 10-11, 1995 (1996) (0)
- Growth hormone deficiency : proceedings of a workshop held in Tübingen on January 17th, 1981 (1983) (0)
- DISORDERS OF WATER BALANCE (2007) (0)
- Prof. Derek Gupta (1997) (0)
- Turner syndrome. (2018) (0)
- Influence of allogeneic bone marrow transplantation on the endocrine system in children. (1989) (0)
- Growth hormone treatment of short children born small for gestational age: Metanalysis of four independent, randomized, controlled, multicentre studies - Panel discussion (1996) (0)
- Growth Hormone Effects on Metacarpal Bone Geometry and Bone Age in Growth Hormone-Deficient Children (2019) (0)
- Front & Back Matter (2014) (0)
- Treatment of idiopathic growth hormone deficiency: Comparison of growth hormone alone with growth hormone plus thyroxine (1978) (0)
- THE VARIABILITY OF OXANDROLONE LEVELS IN SERUM AND URINE POSES NEW QUESTIONS TO ITS USE FOR TREATMENT OF CDGA (1993) (0)
- Stimulation der gastralen Reparation durch einmalige Infiltration von Insulin-Like-Growth-Factor I (IGF-I) (1997) (0)
- Contents Vol. 80, 2013 (2014) (0)
- Contents Vol. 75, 2011 (2011) (0)
- Discussion (1990) (0)
- Contents Vol. 80, 2013 (2014) (0)
- THYROID DISORDERS (2007) (0)
- Birth Characteristics Influence the Male to Female Diagnostic Prevalence of Idiopathic GH Deficiency (2015) (0)
- DISORDERS OF PUBERTY (2007) (0)
- The value of IGF-I, IGF-II, and somatomedin binding protein for the diagnosis of growth hormone deficiency (1989) (0)
- Insulin-like Growth Factors (IGF) I und II und IGF-bindendes Protein 3 (IGF-BP-3) bei polytraumatisierten Patienten (1992) (0)
- PITUITARY, HYPOTHALAMUS, CENTRAL NERVOUS SYSTEM (CNS) (2007) (0)
- Growth and development: Bone dysplasia—a frequent cause of short stature in children (2014) (0)
- Front & Back Matter (2012) (0)
- Preface (2006) (0)
- A PREDICTION MODEL FOR THE FIRST YEAR GROWTH RESPONSE TO GROWTH HORMONE IN TURNER SYNDROME (TS) BASED ON KIGS (Kabi Pharmacia International Growth Study) DATA (1993) (0)
- Cholestasis in neonates with congenital combined pituitary hormone deficiency: there is etiology besides endocrinology (2005) (0)
- Title Page / Table of Contents (2002) (0)
- Contents Vol. 78, 2012 (2013) (0)
- 96 STRUCTURAL VARIANTS OF SOMATOMEDINS IN HUMAN PLASMA (1985) (0)
- Growth effect of GH therapy administered for a year to children with Terner’s syndrome. Analysis of international data base on growth monitoring of the Kabi Farmacia company (1994) (0)
- Diagnostics: Appendix A (2003) (0)
- Subject Index Vol. 51, 1999 (1999) (0)
- Front & Back Matter (2017) (0)
- Discussion (1991) (0)
- PELVIC ULTRASONOGRAPHY IN SEXUAL PRECOCITY. AUTHORS'REPLY (1997) (0)
- Age-dependent effects of cyproterone acetate (CA) on growth and peripheral hormones in the male rat (1981) (0)
- Introduction (1988) (0)
- [Pubertas praecox in McCune-Albright syndrome--case report and review of the literature]. (1987) (0)
- BONE TURNOVER AND GROWTH IN CHILDREN FOLLOWING ACUTE ONST OF PERTHES DISEASE (2003) (0)
- Stimulation der gastralen Reparation durch einmalige Infiltration von Insulin-Like-Growth-Factor I (lGF-1) Stimulation of gastric repair by single infiltration of Insulin-like-growth-factor I (lGF-1) (1997) (0)
- Serum Insulin-Like Growth Factor I Reference Values for an Automated Chemiluminescence (2016) (0)
- Development of Thyroid Function in Very Low Birth Weight Infants During the First Months of Life (2007) (0)
- New Perspectives in GH Research: Davos, March 2002 (2002) (0)
- Short Stature and Chromosomal Abnormalities (2004) (0)
- Author's response to reviews Title: Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pfizer International Growth Database) Authors: (2011) (0)
- Author's response to reviews Title: Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pfizer International Growth Database) Authors: (2011) (0)
- Preface (2004) (0)
- Accurate long-term prediction of height development during growth hormone (GH) treatment in prepubertal children with growth hormone deficiency (GHD) and Turner syndrome (TS) (2011) (0)
- International Symposium Frontiers of Paediatric Neuroendocrinology (1993) (0)
- Methods to Determine Insulin Sensitivity in Clinical Practice. Growth Hormone and Cognition (2006) (0)
- Subject Index Vol. 68, Suppl. 5, 2007 (2007) (0)
- hGH Symposium: 10th Symposium, Seville, April 1999 (1999) (0)
- hGH Symposium: 12th Symposium, Keystone, June 2001 (2001) (0)
- [Physical and mental development of hypathyroid children being treated with synthetic thyroid hormone (author's transl)]. (1974) (0)
- Measurement of Immunofunctional Leptin to Detect Patients with Functional Leptin Deficiency (2016) (0)
- Circulating levels of DHA in growth hormone (GH) deficient children with normo-synthesis of cortisol (1979) (0)
- Growth Hormone Treatment in Neurofibrosis Type 1 Involving Central Nervous System Tumours and Pituitary Langerhans Cell Histiocytosis within KIGS (2007) (0)
- patients with dilated cardiomyopathy are independent predictors of a poor prognosis in Insulin-like growth factor-binding proteins 2 and 3 (2007) (0)
- Book Review / Erratum (1994) (0)
- Haploinsufficiency in School-Age Children with Unexplained Short Stature SHOX Auxology Is a Valuable Instrument for the Clinical Diagnosis of (2003) (0)
- 59 GROWTH-RELATED HORMONAL CHANGES AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION (BMT) IN CHILDREN AND ADOLESCENTS (1988) (0)
- CIGssificGfion of growfh insensitivity syndrome (1993) (0)
- Subject Index Vol. 78, 2012 (2013) (0)
- Turner's syndrome. (1997) (0)
- P36 Trends in the incidence of childhood diabetes: Results of a 10-year study in Baden-Wuerttemberg, Germany (1999) (0)
- Contents Vol. 60, 2003 (2003) (0)
- PIH67 Successful Development of Annual and Long Term Prediction Models to Estimate Height Outcome following Growth Hormone (GH) Therapy in Children Using Data from KIGS – A Large Pharmacoepidemiological Survey (2011) (0)
- [Somatomedin and growth]. (1985) (0)
- GHD during Critical Phases of Life (2016) (0)
- 164 Insulin-Like Growth Factors and Their Binding Proteins in Early Milk from Mothers of Preterm and Term Infants and Thei Biological Relevance (2004) (0)
- Associations between Total Leptin, Bio-inactive Leptin, Soluble Leptin Receptor and Anthropometrics in Children with Severe Early-onset Obesity (SEOO) - the German-Polish Study (EOL-GPS) (2018) (0)
- Patients with Silver-Russell-Syndrome from Birth to Adulthood: Diagnosis, Development and Medical Care. (2017) (0)
- Growth and GH Treatment of Children Born Small for Gestational Age, Body Composition: 2nd KIGS Expert Meeting on Growth and Growth Disorders, Meeting, Lake Como, November 1996 (1997) (0)
- Symposium ‘Functional Role of IGFBPs’ (2002) (0)
- Somatomedin binding protein and somatomedin C are reliable indicators of acromegalic activity (1989) (0)
- GROWTH IN THE NOONAN SYNDROME (NS) (1988) (0)
- Oral Session: Graft Versus Malignancy/Minimal Residual Disease (2003) (0)
- Subject Index Vol. 66, Suppl. 1, 2006 (2007) (0)
- Subject Index Vol. 71, Suppl. 2, 2009 (2009) (0)
- Subject Index Vol. 60, 2003 (2003) (0)
- [Growth effect during the first year of growth hormone therapy in children with Turner's syndrome. Analysis of an international database on growth monitoring of the Kabi Farmacia company]. (1994) (0)
- DISORDERS OF GLUCOSE AND TRIGLYCERIDE METABOLISM (2007) (0)
- Contents / Foreword / User Guide (2007) (0)
- Foreword (2002) (0)
- [Fish meal and Salmonellae]. (1967) (0)
- Contents, Vol. 44, 1995 (1995) (0)
- ADRENAL DISORDERS (2007) (0)
- Growth hormone level during stimulation test and efficacy of growth hormone therapy of idiopathically undersized children with this hormone insufficiency (1993) (0)
- Growth Hormone and Endocrinology: 13th Novo Nordisk Symposium and SGA/IUGR Satellite Symposium, Budapest, April 2002: Proceedings (2003) (0)
- Comparison of circulating human growth hormone measured by radioimmunoassay (RIA) and radioreceptorassay (RRA) in plasma of children (1978) (0)
- Growth and GH treatment of children born small for gestational age, body composition : 2nd KIGS Expert Meeting, Lake Como, Italy, November 7-8, 1996 (1997) (0)
- THE SHORT-TERM INCREASES OF IGF-I AND IGFBP-3 DURING GH TREATMENT PREDICT THE LONG-TERM GROWTH RESPONSE IN SHORT CHILDREN (1993) (0)
- [New aspects in the diagnosis of herpes simplex virus encephalitis--case reports and virologic findings]. (1992) (0)
- Longitudinal Development of CICP in Preterm Neonates 219 (1996) (0)
- Preliminary Pages / Table of Contents / Preface / Preface to the Second Edition / Preface to the First Edition / Before Using This Book (2003) (0)
- Title Page / Contents (1999) (0)
- Standardization of growth hormone measurement, evidence-based medicine : 3rd KIGS/KIMS Expert Meeting on Growth and Growth Disorders, Sorrento, Italy, November 19-20, 1998 /guest editors, M. B. Ranke and J. Dowie (1999) (0)
- Late effects after Chemotherapy versus Allogeneic Stem Cell Transplantation in Childhood Relapsed Acute Lymphoblastic Leukemia - A report from the ALL-REZ BFM Study Group (2012) (0)
- DISORDERS OF BONE METABOLISM, INCLUDING CALCIUM/PHOSPHATE METABOLISM (2007) (0)
- Summary (1988) (0)
- Subject Index Vol. 75, 2011 (2011) (0)
- Lower Leg Length and Cicp in Aga and Sga Preterm Neonates (1997) (0)
- Session 33. Reproductive endocrinology (1990) (0)
- HEIGHT DEVELOPMENT IN TURNER SYNDROME (TS): RESULTS OF AN INTERNATIONAL SURVEY CONDUCTED BY ESPE/LWPES (1993) (0)
- Front & Back Matter (2012) (0)
- Commentary to the ESPE Statements on the Safety of Human Growth Hormone Therapy (1993) (0)
- John Scott Parks (October 1939–December 2021) (2022) (0)
- Clinical, genetic, and epidemiological survey of Polish children and adolescents with severe obesity: A study protocol of the Polish–German study project on severe early-onset obesity (2022) (0)
- Near-Adult Height in a Large Cohort of Patients with Turner Syndrome and Noonan Syndrome Treated with rhGH: Results from Pfizer International Growth Database (2016) (0)
- A Novel Method for Adult Height Prediction in Children With Idiopathic Short Stature Derived From a German-Dutch Cohort (2022) (0)
- Changes of TSH secretion in goitrous children treated with potassium iodide (1978) (0)
- EVALUATION OF INSULIN-LIKE GROWTH FACTOR (IGF) II AS A DIAGNOSTIC TOOL IN GRWOTH HORMONE DEFICIENCY (GHD) (1988) (0)
- Spontaneous Growth in Patients with Noonan Syndrome (1995) (0)
- Front & Back Matter (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Michael Bernd Ranke?
Michael Bernd Ranke is affiliated with the following schools:
